Nutilis

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nutilis

Quick Facts

Property Description
Active ingredient Maltodextrin, Modified Starch, Hydrocolloidal Gums
Form Powder, Ready-to-drink nutritional supplement
Pharmacological class Fluid Thickener, Consistency Maintenance Agent
Common use Dietary management of dysphagia
Origin Derived (from corn/maize and plant seeds)

What is Nutilis Classified As?

Nutilis (manufactured by Nutricia) is classified as a Food for Special Medical Purposes and a specialized Preparation for Enteral Nutrition, functioning as an oral Fluid Thickener and Food Thickener. It is not a conventional drug but a medically supervised combination product designed for patients with specific clinical dietary needs.

Its high-level pharmacological classification places it within the category of consistency maintenance agents used for the dietary management of dysphagia (swallowing difficulties). The product's overriding purpose is to improve the safety of ingestion, a function involving texture modification in dysphagia management.

Key Ingredients and Formulation Type

The product is commonly presented as a versatile, flavorless Powder and in some variants, a Ready-to-drink nutritional supplement, tailored for use primarily in adults. The formulation contains a blend of active thickening agents, including Maltodextrin, Modified Starch, and hydrocolloidal Gums such as Xanthan Gum, Guar Gum, and Tara Gum.

A critical differentiating feature of Nutilis is its amylase-resistant feature, which is designed to protect the thickened consistency from being immediately broken down by the salivary amylase enzyme in the mouth, ensuring consistent texture during the swallow. This resistance is clinically recognized as essential for aspiration risk reduction.

How Nutilis Achieves Swallowing Safety

Nutilis improves swallowing safety through targeted Viscosity Adjustment, which slows the flow rate of fluids and improves the cohesiveness of puréed foods. This texture modification provides the user with increased time to control the bolus and coordinate the swallow reflex effectively.

The product's functional standards are frequently benchmarked against the clinical levels of the IDDSI Framework (International Dysphagia Diet Standardisation Initiative), which ensures the product achieves consistent and specific thickness levels. By reliably adjusting consistency to clinical specifications, Nutilis supports patients with swallowing difficulties by ensuring adequate hydration and minimizing the major health risk associated with aspiration.

What side effects are possible with Nutilis?

The safety documentation for Nutilis, which is classified as a Food for Special Medical Purposes (FSMP), is structured around safety restrictions and contraindications rather than a conventional list of pharmacological side effects found in drug labels.

Adverse Reaction Scope

Category Description
Key Adverse Reactions Conventional frequency-classified side effects are not listed in regulatory documents. The safety focus is on patient suitability and product handling.
Frequency Classification None listed. Standard regulatory frequency categories (e.g., Common, Rare) are not specified for this product.
System-Organ Classes Safety constraints relate to Metabolic conditions (e.g., galactosaemia) and Gastrointestinal dietary needs (e.g., requirement for a fibre free diet, for certain variants).
Serious Safety Risks The primary serious risk is increased aspiration or choking if the product is improperly prepared or misused, which defeats the product’s intended purpose. The product is also not for intravenous use due to the potential for serious harm.
Population Safety Not suitable for children under 3 years of age. Contraindicated in patients with galactosaemia and certain variants are unsuitable for those on a fibre free diet.
Safety-Related Restrictions Use must be strictly under medical supervision; the product is intended for enteral use only; and it is not suitable as a sole source of nutrition.

Safety Classifications (High-Level)

Classification Details
Regulatory Basis Based on regulatory requirements for Foods for Special Medical Purposes (FSMP) and associated official health authority guidance.
Context-of-Use Notes There is an officially documented potential for an interaction between starch-based thickeners (such as some Nutilis variants) and polyethylene glycol (PEG) laxatives, which can cause the thickened liquid to thin out, thus increasing the risk of aspiration. Separate use is required.

Resulting Safety Structure

The overall safety profile is defined by official constraints designed to ensure correct usage and patient selection. These constraints highlight that the main risks are linked to: non-adherence to the prescribed administration route (enteral only), unsuitability for certain metabolic conditions, and the potential failure of the thickening effect if mixed improperly or with incompatible substances like PEG laxatives.

Overdose and Emergency Response

Nutilis Overdose and when to seek help

The regulatory profile for overdose, defined by the consequences of excessive intake of this Food for Special Medical Purposes, focuses on localized and metabolic risks rather than systemic toxicity.

Documented Manifestations Official Regulatory Statements
Gastrointestinal Effects Excessive consumption is associated with localized gastrointestinal symptoms, including bloating, flatulence, and abdominal discomfort, due to the bulk-forming nature of the hydrocolloidal gums and starches.
Metabolic Risk The Maltodextrin component introduces a specific, documented risk for acute blood glucose elevation in individuals with diabetes or insulin resistance. This necessitates patient monitoring in such cases.
Required Emergency Action Official Regulatory Statements
When to Seek Help Seek immediate medical attention is required for severe discomfort, difficulty breathing, or any suspected mechanical obstruction. Seek medical advice if gastrointestinal symptoms persist or worsen significantly.
Management Symptomatic and supportive treatment is the required regulatory approach for over-ingestion. No specific antidote is known, consistent with the product's low systemic toxicity and classification.

The official profile defines the overdose structure around managing the physical consequences of the components. The mandated help-seeking guidance ensures immediate medical attention is sought when symptoms, particularly those related to breathing or acute metabolic change, become severe.

Therapeutic Uses of Nutilis

What Nutilis Treats: Main Uses and Benefits

Nutilis is commonly used to help with the management of oropharyngeal dysphagia, a condition characterized by symptoms that interfere with daily functioning, such as difficulty swallowing liquids and certain foods. It may be part of symptomatic management when symptoms related to liquid and food intake create noticeable physiological strain, such as coughing, choking, or the fear of aspiration.

A key therapeutic benefit contributes to improved swallowing safety. By modifying the viscosity of fluids, Nutilis supports a safer flow, which may assist with reducing the immediate safety risks linked to aspiration. This is relevant in situations with significant discomfort in conditions involving episodic or fluctuating manifestations. The product is commonly used to help with reducing the risk of aspiration and supports hydration.

Nutilis generally offers a supportive benefit by enabling patients to safely consume essential fluids and oral nutritional supplements. This is applied in scenarios where additional management of discomfort is required due to the fear of swallowing. In situations where adequate fluid intake is a challenge, the product assists with maintaining functional stability, which contributes to improved day-to-day comfort during symptomatic periods.

Quick Fact: Support for Swallowing Strain

Regulatory References

  1. Guide to Prescribing Thickeners for Adults

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Rules

Nutilis is a Food for Special Medical Purposes whose use is governed by official labeling that defines specific populations who can and cannot use the product. These eligibility rules are based on patient age, metabolic conditions, and the intended route of administration.

Classification Population Restriction as per Labeling
Absolute Contraindications Not suitable for children under three years of age.
Not suitable for patients with Galactosaemia.
Not suitable for patients requiring a fibre free diet (applies to fibre-containing variants).
The powder variant is Not for intravenous use (parenteral administration).
Conditional Use (Precautions) Use with caution is required in children aged three to six years.
Not suitable as a sole source of nutrition in children under six years of age.
Use with caution in patients on a sodium restricted diet (for Nutilis Clear variant).

Allowed Populations

Adults and children three years of age and older are the generally accepted populations for the dietary management of dysphagia and associated medical conditions, provided no contraindications are present. The product must be used strictly for enteral use only and always under medical supervision. The official labeling does not include specific restrictions or recommendations for use during pregnancy or lactation.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Nutilis's interaction profile is documented in official government sources and is primarily based on the physical properties of its thickening agents (starch and hydrocolloidal gums) and their chemical interaction with certain medicines.

Documented Interaction Patterns

Classification Interacting Substances Official Regulatory Constraint
Pharmacodynamic Incompatibility Starch-based thickeners (e.g., Nutilis Powder) and Polyethylene Glycol (PEG) laxatives (e.g., macrogol, Movicol). Authorities advise avoiding direct mixing as this interaction counteracts the thickening action, resulting in a thin, watery liquid.
Exposure-Altering Interaction Xanthan gum-based thickeners (e.g., Nutilis Clear) and select medications (e.g., Amitriptyline, Tamoxifen, Verapamil). The interaction may cause reduced or delayed drug dissolution, impacting the medication's absorption.
Administration Constraint Solid oral medications with thickened fluids. Official guidelines suggest administering certain incompatible medicines with a spoonful of soft food rather than mixed into thickened fluid to mitigate dissolution risk.

Population-Specific Notes

The documented incompatibility between PEG laxatives and starch-based thickeners presents a heightened risk of aspiration for elderly people and individuals with swallowing disabilities, leading to specific cautions in official regulatory communications.

Mechanism of Action

How Nutilis Works

The action of Nutilis is entirely physical and peripheral, modulating the rheological properties of the liquid being swallowed rather than acting on biological processes in the body. Its mechanism relies on two key domains: Viscosity Modification and Enzymatic Stability, which synergistically influence bolus dynamics.

1. Viscosity Modification and Bolus Cohesion

This domain addresses the product’s core physical action on the swallowed material. Hydrocolloid components disperse in the liquid to form a stable, shear-thinning network, resulting in a significant increase in viscosity and cohesion. This mechanism primarily affects fluid dynamics in the mouth and throat, resulting in a slower pharyngeal transit time that allows for enhanced influence over bolus trajectory, which increases the temporal margin for laryngeal protective responses.

2. Resistance to Salivary Amylase

This domain ensures the effect of the first domain is maintained. The biopolymer formulation exhibits high resistance to hydrolysis by salivary alpha-amylase, the enzyme naturally present in saliva that breaks down starches. This mechanism of enzymatic stability ensures the modified consistency is maintained consistently throughout the oral and pharyngeal phases. The sustained consistency maintains the modified flow characteristics, allowing the temporal effect of slower transit to operate without reduction.

Dosage and Administration Information

Official Administration Guidelines

Nutilis is classified as a Food for Special Medical Purposes, and its usage is strictly guided by prescriptive clinical protocols and mandatory medical supervision. The product is intended only for oral administration as a fluid and food thickener, and is not suitable for use via feeding tubes or intravenous injection.

Consistency and Dosing Principles

The dosage administered is highly individualized and determined by a healthcare professional, such as a dietitian or Speech and Language Therapist. This quantity is not a fixed drug dose but is dictated by the required consistency level, which must align with the four primary stages of the International Dysphagia Diet Standardisation Initiative (IDDSI) framework. The administration schedule is continuous and applied per serving of liquid or food, tailored to the patient’s overall daily fluid requirements and feeding schedule.

Preparation and Procedural Rules

Preparation involves the vigorous stirring of the powder using only the specific scoop provided with the container. After mixing, a mandatory standing time of 5 to 10 minutes is required for the mixture to achieve its final, stable prescribed viscosity. The prepared liquid or food can be mixed when hot or cold, and may subsequently be chilled, frozen, or reheated. To maintain product integrity, prepared portions must be consumed within two hours or discarded.

Age-Group Restrictions

Official information clearly restricts the use of Nutilis, stating that it is not suitable for infants and children under the age of 3 years.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nutilis

Research Evidence for Oropharyngeal Dysphagia in Adults

Research has examined studies for this food and fluid thickener in adult populations with swallowing difficulties, a condition characterized by functional limitations. The available studies, which include short-term randomized controlled trials and observational settings, were conducted during periods of increased symptom activity. Researchers primarily monitored outcomes related to systemic or functional imbalance, such as the risk of aspiration (when food or liquid enters the airway) and the rate of respiratory infections.

Studies describe patterns observed in the immediate, short-term use of the product, particularly concerning instrumental measures of swallowing safety. Research describes measurements related to how the bolus (the mass of food or liquid being swallowed) moved through the pharynx in the study populations. Studies examined clinical outcomes such as aspiration pneumonia incidence; reported findings varied across different long-term observational studies.

Research Evidence for Post-Stroke Dysphagia

The majority of focused research was observed in patients with swallowing difficulties following a stroke, a condition associated with acute or disruptive episodes. Studies conducted during periods of increased symptom activity examined temporary physiological imbalance, specifically focusing on how the mechanics of swallowing were measured. Research explored short-term symptom changes and used specialized instrumental techniques to monitor physical outcomes like how quickly the laryngeal protective mechanisms close.

Studies report that specific kinematic measurements were collected during the study period, particularly when the fluid was thickened to various consistency levels. The findings describe patterns related to measurements of swallowing function taken during the study period. Studies report how symptoms evolved in the observed populations in the context of controlled consumption. However, these findings describe group patterns, not personal outcomes, and the results apply only to the specific populations studied.

Key Limitations and Research Gaps

Research so far indicates several areas where the evidence is limited. Follow-up durations were limited in existing studies, meaning there is a lack of characterization for long-term outcomes. Furthermore, sample sizes were modest in several instrumental studies, and evidence quality varies across studies. The data show patterns related to instrumental effects, but the extent to which these correlate with sustained clinical outcomes, such as pneumonia incidence over a year or more, remains uncertain. Certainty remains low regarding the ideal, individualized viscosity level for every patient, as findings were mixed on which consistency provided the best balance of safety and clearance for various patient types.

Key Studies & References

  1. Acceptance of different types of thickeners, with and without flavoring, in hospitalized patients with dysphagia - a pilot study

Frequently Asked Questions (FAQ)

Common questions about Nutilis (FAQ)


Q: What is the difference between Nutilis and other products that serve a similar purpose?

The official product information describes a critical feature of Nutilis Powder and Nutilis Clear as being amylase-resistant. This means the formulation is designed to maintain the required thickness of the liquid even when it mixes with saliva in the mouth. This resistance helps prevent the starch in the product from being broken down by the natural salivary amylase enzyme, supporting a consistent texture throughout the swallowing process.


Q: Can Nutilis change the way my other daily vitamins or supplements work?

Official guidance warns that combining dietary supplements and medications may affect drug absorption or metabolism, which could lead to unexpected effects on your health. Because of the potential for reduced or delayed absorption, consultation with a healthcare professional is generally recommended when considering the use of supplements or vitamins alongside Nutilis.


Q: Are there specific food or drink types that should be avoided when taking Nutilis?

Official product instructions and regulatory documents highlight the importance of avoiding direct mixing of starch-based thickeners with Polyethylene Glycol (PEG) laxatives, as this can thin the fluid and affect the product’s intended purpose. Regarding carbonated drinks, the instructions note that they should be stirred well until they are flat before Nutilis is added.


Q: Has Nutilis been studied in children or older adults specifically?

Product information is often presented in the context of 'Aged Care' and for the dietary management of swallowing difficulties following a stroke. These are conditions most common in older adult populations, which implies the target audience for much of the available evidence. Specific regulatory guidance provides age restrictions for its use.


Q: Does Nutilis interact with common over-the-counter pain relievers?

While specific over-the-counter (OTC) pain relievers are not named in official interaction tables, general regulatory information cautions that thickeners can cause reduced or delayed dissolution of solid medications. This may impact the absorption rate of any medication, including OTC pain relievers, when administered with the thickened fluid.


Q: How does Nutilis compare to simply eating a balanced diet?

According to official product labeling, Nutilis is not designed to be used as a sole source of nutrition. It is classified as a Food for Special Medical Purposes and serves exclusively as a food and fluid thickener. Its primary role is to help manage swallowing difficulties (dysphagia) as part of a patient’s overall prescribed diet.


Q: Are there different formulas or flavors of Nutilis?

Yes, Nutilis is available in different formulas depending on the patient's needs. These include the powdered thickeners, like Nutilis Powder and Nutilis Clear, and nutritional supplements such as the Nutilis Complete range. The nutritional supplements are often pre-thickened to different viscosity levels and are sometimes available in various flavors.


Q: Does Nutilis require a prescription from a doctor?

As a Food for Special Medical Purposes, Nutilis must be used strictly under the mandatory supervision of a healthcare professional. In many regions, the product is approved for prescribing (ACBS approved) and can be obtained on a standard prescription form, which dictates how the product is accessed and reimbursed.


Q: What is the shelf life of Nutilis?

The unopened product typically has a shelf life of around 18 months from its date of manufacture. Once the container is opened, the powder inside must be used within two months. Any food or drink prepared with Nutilis must be consumed within a two-hour window.


Q: How quickly do people typically notice an effect from Nutilis?

The effect of Nutilis on the liquid is rapid after preparation. The instructions require a mandatory standing time of about 5 to 10 minutes after vigorous stirring to allow the mixture to achieve its final, stable consistency before consumption. The physical effect on swallowing then occurs immediately upon ingestion of the thickened fluid.


Q: How long does the effect of Nutilis last after it's been taken?

The physical effect is active during the swallowing process. The product is designed with an amylase-resistant feature, which helps to ensure the texture of the thickened food or drink remains stable and consistent while it is in the mouth. This consistency maintenance is vital for supporting the patient's swallowing mechanism.


Q: Does Nutilis have any significant impact on weight or appetite?

Nutilis Powder is low in protein, fat, and calories, and is not generally intended to contribute significantly to the patient's overall nutritional intake or impact appetite. However, other variants like Nutilis Complete are high-calorie, pre-thickened supplements specifically formulated for the dietary management of disease-related malnutrition.


Q: Is Nutilis suitable for people who are lactose intolerant?

Official nutritional information indicates that Nutilis Powder has a low lactose content (lactose less than 2 g/100 g). Other products in the Nutilis line are also documented as having low lactose levels.


Q: Is Nutilis covered by insurance or government health plans?

Yes, in certain regions where Nutilis is officially recognized, it is ACBS approved (Advisory Committee on Borderline Substances). This approval means the product is prescribable on standard government health forms, which sets a mechanism for its coverage or subsidy under medical supervision.


Q: Is Nutilis gluten-free?

According to official product labeling, Nutilis Powder is verified to have no detectable gluten (less than 5 ppm). The ready-to-drink nutritional supplements in the Nutilis Complete line are explicitly labelled by the manufacturer as being gluten-free.


Q: Can Nutilis be used by people with diabetes?

The powdered version of Nutilis is primarily carbohydrate-based, and its use, like all Foods for Special Medical Purposes, must be monitored by a healthcare professional. They are responsible for considering a patient's total carbohydrate intake and overall health status, particularly in the context of conditions like diabetes.


Q: Can Nutilis be mixed with carbonated drinks?

Yes, the directions for using Nutilis Clear explicitly state that it can be mixed with carbonated drinks. To ensure proper thickening, the instructions require stirring the carbonated drink well until the liquid has gone flat before the thickener powder is added.


Q: Does Nutilis contain any common allergens?

Official product labels provide detailed allergy advice, confirming that Nutilis products are free from common allergens such as wheat, egg, and nuts. Additionally, the powder is verified to have no detectable gluten. The manufacturer also lists the product as compatible with Halal and Kosher diets.


Q: What are the rules about combining Nutilis with herbal products?

Consultation with a healthcare professional is strongly recommended before combining any prescribed medical food or thickener with herbal supplements. This precaution is due to the potential for unknown interactions that could affect the product's function or the potency of the herbal supplement.

How should Nutilis be stored and disposed of?

The storage and disposal of Nutilis are governed by specific product stability and safety instructions detailed in the official labeling.

Storage Requirements

  • Temperature and Environment: The product must be kept sealed and stored in a cool, dry place. The regulated temperature range is typically specified as 5 C to 25 C. Some labels explicitly state: Do not refrigerate [1.2, 1.3].
  • Container Integrity: After opening, the lid must be replaced firmly after each use to protect the powder from moisture and maintain integrity [1.2].
  • Child Safety: The product must be kept out of the reach of children [1.1].

Stability and Disposal Instructions

  • Opened Tin Life: Once the container is opened, the contents must be used within 8 weeks (or 2 months, depending on the product variant) and any remaining powder must be discarded after this period [1.2, 1.4].
  • Prepared Product: Thickened food or drink prepared with Nutilis must be used within 2 hours [1.2]. Unfinished prepared portions must always be discarded after this 2-hour window [1.3].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nutilis found in:

A-Z Index: